TY - JOUR
T1 - Insulin resistance in uremia
T2 - In vitro model in the rat liver using human serum to study mechanisms
AU - Folli, Franco
AU - Sinha, Madhur K.
AU - Brancaccio, Diego
AU - Caro, Jose F.
N1 - Funding Information:
From the Department of Medicine. Section of Endocrinology and Metabolism, East Carolina University School of Medicine, Greenville, NC. Supported by NIH Grant No. ROI-AM32585-04. Address reprint requests to .Iose F. Caro. MD, Department of Medicine, Section of Endocrinology and Metabolism, School of Medicine. East Carolina University, Greenville, MC 27834-4354. a 1986 by Grune & Stratton, Inc. 0026-0495/86/3511~003803.00/0
Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 1986/11
Y1 - 1986/11
N2 - We have previously demonstrated in a rat model of chronic uremia that the liver is resistant to insulin. To further investigate the mechanism(s) of insulin resistance in uremia, primary cultures of normal rat hepatocytes were incubated with varying dilutions ( 1 10 to 1 10,000) of sera from undialyzed end stage uremic and normal humans for 20 hours. We then studied insulin action, binding, and postbinding events. Dilutions of uremic sera as low as 1 1,000 rendered the hepatocytes resistant to maximal concentrations of insulin with regard to [14C]acetate incorporation into lipids. The dose response curve for insulin-stimulated [14C]aminoisobutyric acid uptake demonstrated a shift to the right in hepatocytes incubated with uremic sera when compared with those incubated with normal sera. The 125I-insulin binding sites and affinity, 125I-insulin internalization and degradation, insulin receptor structure, autophosphorylation of the insulin receptor, and its tyrosine-specific kinase activity were normal in the hepatocytes rendered resistant to insulin by uremic sera. However, these cells failed to generate the chemical mediator or second messenger of insulin action, as assessed by its ability to stimulate pyruvate dehydrogenase (PDH) in liver mitochondria from normal rats. We concluded that uremic sera renders normal rat hepatocytes resistant to insulin. Insulin resistance is a postinsulin receptor kinase defect possibly due to lack of the generation of the chemical mediator of insulin action. This in vitro cell model may be useful to further define the mechanism(s) and the serum factor(s) responsible for insulin resistance in uremia in the absence of complicating hormonal and substrate changes that occur in vivo.
AB - We have previously demonstrated in a rat model of chronic uremia that the liver is resistant to insulin. To further investigate the mechanism(s) of insulin resistance in uremia, primary cultures of normal rat hepatocytes were incubated with varying dilutions ( 1 10 to 1 10,000) of sera from undialyzed end stage uremic and normal humans for 20 hours. We then studied insulin action, binding, and postbinding events. Dilutions of uremic sera as low as 1 1,000 rendered the hepatocytes resistant to maximal concentrations of insulin with regard to [14C]acetate incorporation into lipids. The dose response curve for insulin-stimulated [14C]aminoisobutyric acid uptake demonstrated a shift to the right in hepatocytes incubated with uremic sera when compared with those incubated with normal sera. The 125I-insulin binding sites and affinity, 125I-insulin internalization and degradation, insulin receptor structure, autophosphorylation of the insulin receptor, and its tyrosine-specific kinase activity were normal in the hepatocytes rendered resistant to insulin by uremic sera. However, these cells failed to generate the chemical mediator or second messenger of insulin action, as assessed by its ability to stimulate pyruvate dehydrogenase (PDH) in liver mitochondria from normal rats. We concluded that uremic sera renders normal rat hepatocytes resistant to insulin. Insulin resistance is a postinsulin receptor kinase defect possibly due to lack of the generation of the chemical mediator of insulin action. This in vitro cell model may be useful to further define the mechanism(s) and the serum factor(s) responsible for insulin resistance in uremia in the absence of complicating hormonal and substrate changes that occur in vivo.
UR - http://www.scopus.com/inward/record.url?scp=0023001459&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023001459&partnerID=8YFLogxK
U2 - 10.1016/0026-0495(86)90034-X
DO - 10.1016/0026-0495(86)90034-X
M3 - Article
C2 - 3534520
AN - SCOPUS:0023001459
VL - 35
SP - 989
EP - 998
JO - Metabolism: Clinical and Experimental
JF - Metabolism: Clinical and Experimental
SN - 0026-0495
IS - 11
ER -